A bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women and men, and to treat Paget's disease of bone. It works by slowing bone loss and increasing bone mass, and was developed by Merck.
including Merc who made Fossamax which was an ant osteoporosis medication.
"
"The speaker mentions Fosamax as an osteoporosis medication made by Merck, highlighting how consultants for the industry (including Merck) influenced the diagnostic criteria for osteoporosis, suggesting a conflict of interest in medical guidelines."





